MOIN ANDREW exercised options at SAB BIOTHERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 11/28/2023ACC: 0000950170-23-066395
+4.58M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
4.61M acquired · 31.27K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+4.58M
Price / share
—
Trade value
—
% of position
New position
11/24/2023
0.00→4.58M
Total
Net shares
+4.58M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/24/2023 | M · Option Exercise | +4.58M | — | — | New position | 0.00 | 4.58M |
| Total | +4.58M | $0.00 | ||||||
Derivative Transactions2
Series A-1 Convertible Preferred Stock
Indirect
Converts to
Common Stock or Series A-2 Convertible Preferred Stock
49.63M shares
Shares
−31.27K
Strike price
0.63
Held after
0.00
Exercisable
—
11/24/2023
Series A-2 Convertible Preferred Stock
Indirect
Converts to
Common Stock
45.05M shares
Shares
+28.38K
Strike price
0.63
Held after
28.38K
Exercisable
—
11/24/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A-1 Convertible Preferred Stock Indirect | Common Stock or Series A-2 Convertible Preferred Stock49.63M shares | 11/24/2023 | M · Option Exercise | −31.27K | 0.63 | — | 0.00 |
| Series A-2 Convertible Preferred Stock Indirect | Common Stock45.05M shares | 11/24/2023 | M · Option Exercise | +28.38K | 0.63 | — | 28.38K |